Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasome subunit beta type-2 is a non-catalytic component of the 20S core proteasome complex, essential for regulated degradation of intracellular proteins. It contributes structurally to the active site environment within the proteasome, playing a role in protein quality control and various cellular processes like cell cycle, signal transduction, immune responses, and apoptosis. While PSMB2 itself lacks direct catalytic activity, it is crucial for proper proteasome assembly and function.
Not applicable (non-catalytic subunit)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome Subunit Beta Type-2 (PSMB2).